BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation

EGFR TKI therapy has become a first-line regimen for non-small cell lung cancer (NSCLC) patients with EGRF mutations. However, there are two big challenges against effective therapy--the secondary EGFR mutation-associated TKI resistance and brain metastasis (BMs) of lung cancer. The BMs is a major c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Main Authors: Yin, Weimin, Zhao, Yuge, Kang, Xuejia, Zhao, Pengfei, Fu, Xuhong, Mo, Xiaopeng, Wan, Yakun, Huang, Yongzhuo
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7255027/
https://ncbi.nlm.nih.gov/pubmed/32483443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.42234
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares